Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04822129 · ClinicalTrials.gov registry record · NA

A Comparison of Two Approaches to Developing Brain Health Programs

A NA study, sponsored by Nova Southeastern University.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT04822129: Completed NA study, sponsored by Nova Southeastern University.

NCT04822129 is a NA study that has completed, run by Nova Southeastern University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04822129, a NA study, has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

This is a research study, designed to test and create new ideas that other people can use. The purpose of this research study is to evaluate two ways of helping people learn to keep their brain healthy. Research has shown that things like exercise, diet, and computer-based cognitive training (doing things that make you think and remember on a computer or tablet) may help older persons maintain their mental functioning as they get older. We want to look at two ways for people to a develop brain healthy lifestyle that they can use and even enjoy. If we find that one of the ways of developing a brain healthy lifestyle is better than the other, other older persons may be able to use it, too. When we say "brain healthy lifestyle," we mean doing things that help to keep you healthy, like exercising and following a good diet. We also mean doing things that may help you think better and maintain your thinking and reasoning as you get older.

Primary Outcome

A composite measure of personal characteristics related to risk for cognitive decline in older persons. Scores range from 0 to 76 with higher scores indicating higher exposures to risk factors for dementia.

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Cogtrastim Model

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2021-04-26
Est. Completion 2022-03-31
Phase NA
Nova Southeastern University

71 total trials

What the finished NCT04822129 record still lists

NCT04822129 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT04822129 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04822129 about?

NCT04822129 is a clinical study titled "A Comparison of Two Approaches to Developing Brain Health Programs". This is a research study, designed to test and create new ideas that other people can use. The purpose of this research study is to evaluate two ways of helping people learn to keep their brain healthy. Research has shown that things like exercise, diet, and computer-based cognitive training (doing ...

What is the current status of trial NCT04822129?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2021-04-26. Estimated completion is 2022-03-31.

What interventions are being tested in trial NCT04822129?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Cogtrastim Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT04822129?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04822129's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04822129, the US trial registry maintained by the National Library of Medicine. NCT04822129 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.